Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Regulatory Information

  • Print
  • Share
  • E-mail
-

Attachment C: List of Key Dates

Prescription Drug Marketing Act Report to Congress (2001): Back to Table of Contents

Previous Section: Attachment B: List of Agency Panel Members at the Hearing

April 22, 1988: The Prescription Drug Marketing Act was signed by the President.

August 26, 1992: PDMA was modified by the Prescription Drug Amendments of 1992.

March 14, 1994: The Agency issued a proposed rule implementing the PDMA.

May 30, 1994: Comment period to close; comment period subsequently was extended to August 15, 1994.

December 3, 1999: The Agency published final regulations in 21 CFR part 203 implementing the provisions of the PDMA.

March 13, 2000: Received petition from U. S. Small Business Administration to reconsider final rule.

March 31, 2000: Received petition from Pharmaceutical Distributors Association to stay implementation of final regulation until October 1, 2001.

March 29, 2000: Met with industry representatives.

May 3, 2000: Agency delayed effective date for certain requirements of the final rule and reopened the administrative record.

May 16, 2000: House Committee on Appropriations issues report accompanying the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill 2001 (report 106-619)

September 19, 2000: Agency announced the public hearing.

October 27, 2000: Agency held public hearing.

November 20, 2000: Comment period on public hearing closed.

February 2001: Agency submits report to Congress.

Prescription Drug Marketing Act Report to Congress (2001): Back to Table of Contents

-
-